Search - tctmd.com

Displaying 81 - 100 of 471

Sort: Relevancy | Date

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

Shelley Wood

September 19, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Shelley Wood

July 20, 2016

News Industry News

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

July 13, 2016

News Daily News

First Published Report From MAC Global Registry Highlights Risks, Opportunities for Transcatheter Mitral Valve Replacement

Shelley Wood

July 11, 2016

News Industry News

Valcare Medical, an Accelmed Portfolio Company, Announces Successful First-In-Human Procedures of the Amend™ Catheter Delivered Annuloplasty Ring

June 20, 2016

Presentation TVT 2016

Tricuspid VIV

Presenter: Danny Dvir

June 17, 2016

Presentation TVT 2016

The 4Tech Approach

Presenter: Fabian Nietlispach

June 17, 2016

Presentation TVT 2016

Trialign

Presenter: Rebecca T. Hahn

June 17, 2016

Presentation TVT 2016

MitraClip

Presenter: Azeem Latib

June 17, 2016

Presentation TVT 2016

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Presenter: Marco Barbanti

June 17, 2016

Presentation TVT 2016

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

Presenter: Creighton W. Don

June 16, 2016

Presentation TVT 2016

TVT 1153: Cardioband Implantation to Treat Recurrent Mitral Regurgitation Due to Annular Dilatation After MitraClip Toward a Surgical Standard

Presenter: Francesco Maisano

June 16, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Conference News EuroPCR 2016

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Shelley Wood

May 26, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

News Industry News

NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation

May 16, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

Advertisement

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

First Published Report From MAC Global Registry Highlights Risks, Opportunities for Transcatheter Mitral Valve Replacement

Valcare Medical, an Accelmed Portfolio Company, Announces Successful First-In-Human Procedures of the Amend™ Catheter Delivered Annuloplasty Ring

Tricuspid VIV

The 4Tech Approach

Trialign

MitraClip

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

TVT 1153: Cardioband Implantation to Treat Recurrent Mitral Regurgitation Due to Annular Dilatation After MitraClip Toward a Surgical Standard

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content